Varex Imaging Corp Q3 2025 Earnings Call Highlights: Revenue Beats Guidance Amid Mixed Segment Performance
PorAinvest
miércoles, 13 de agosto de 2025, 3:09 pm ET1 min de lectura
VREX--
Despite the positive signs, total revenue was down 3% YoY, with the medical segment declining by 4%. Operating expenses were unusually high at $148 million, primarily due to a non-cash goodwill impairment charge of $94 million. This resulted in an operating loss of $81 million and a net loss of $89 million on a GAAP basis [1].
The company successfully paid off $200 million in convertible notes, reducing overall debt and simplifying the capital structure. Sales in China were better than forecasted, with a 4% YoY increase, contributing 15% of total revenues [2].
Varex Imaging Corp's Chief Executive Officer, Sunny Sanyal, expressed optimism about the continued adoption of its systems in cargo inspection applications and a healthy demand environment for both Medical and Industrial segments to drive sales growth of approximately 3% for fiscal year 2025 [1].
References:
[1] https://www.vareximaging.com/news/varex-announces-financial-results-for-third-quarter-fiscal-year-2025/
[2] https://ca.finance.yahoo.com/news/varex-imaging-corp-vrex-q3-074119601.html
Varex Imaging Corp reported Q3 2025 revenue of $203mln, exceeding guidance. The industrial segment showed strength, with a 1% YoY increase in revenue. Non-GAAP gross margin was 34%, surpassing expectations. However, total revenue was down 3% YoY, with the medical segment declining by 4%. Operating expenses were unusually high, resulting in an operating loss of $81mln and a net loss of $89mln on a GAAP basis.
Varex Imaging Corp (Nasdaq: VREX) reported its unaudited financial results for the third quarter of fiscal year 2025, revealing a mixed performance. The company reported revenue of $203 million, exceeding the high end of its guidance. The industrial segment showed strength, with a 1% year-over-year (YoY) increase in revenue. However, the company's non-GAAP gross margin was 34%, surpassing expectations due to higher volume and favorable product sales mix [1].Despite the positive signs, total revenue was down 3% YoY, with the medical segment declining by 4%. Operating expenses were unusually high at $148 million, primarily due to a non-cash goodwill impairment charge of $94 million. This resulted in an operating loss of $81 million and a net loss of $89 million on a GAAP basis [1].
The company successfully paid off $200 million in convertible notes, reducing overall debt and simplifying the capital structure. Sales in China were better than forecasted, with a 4% YoY increase, contributing 15% of total revenues [2].
Varex Imaging Corp's Chief Executive Officer, Sunny Sanyal, expressed optimism about the continued adoption of its systems in cargo inspection applications and a healthy demand environment for both Medical and Industrial segments to drive sales growth of approximately 3% for fiscal year 2025 [1].
References:
[1] https://www.vareximaging.com/news/varex-announces-financial-results-for-third-quarter-fiscal-year-2025/
[2] https://ca.finance.yahoo.com/news/varex-imaging-corp-vrex-q3-074119601.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios